Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...

Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X “I was a little butthurt I didn’t get to hand her one of the bracelets I made for her,” Travis ...

The future of defense strategy requires restructuring forces for modern threats, focusing deployments on critical regions, accelerating tech integration, reforming procurement and budgets, ...